Research programme: antibody-drug conjugates - Innovent Biologics
Latest Information Update: 05 Jul 2021
At a glance
- Originator Innovent Biologics
- Class Antibodies; Drug conjugates; Immunoconjugates
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Unspecified